HIV 1 News and Research

RSS

EMA grants accelerated assessment to Boehringer Ingelheim's Faldaprevir compound

The application for European marketing authorisation of faldaprevir, a potent second generation oral protease inhibitor, has been fully validated and granted accelerated assessment by the European Medicines Agency (EMA).

26 Nov 2013

Global health organizations join forces to raise awareness on dangers of fake medicines

Fake medicines increasingly put patients and the general public at risk across the world. In response to this challenge, ten partners who represent healthcare professionals, disease-specific organizations, product-development partnerships, foundations, international financing institutions, as well as the research-based pharmaceutical industry have joined forces to raise awareness about the dangers of fake medicines.

26 Nov 2013

CRISPR-Cas-system: A promising tool for genetic engineering

Viruses cannot only cause illnesses in humans, they also infect bacteria. Those protect themselves with a kind of 'immune system' which - simply put - consists of specific sequences in the genetic material of the bacteria and a suitable enzyme. It detects foreign DNA, which may originate from a virus, cuts it up and thus makes the invaders harmless.

25 Nov 2013

CHMP recommends approval of Otsuka's Deltyba for pulmonary multidrug-resistant tuberculosis

Otsuka Pharmaceutical Co., Ltd. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Deltyba (delamanid) in combination with a WHO recommended optimized background regimen for the treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB). The CHMP opinion will help form the basis for a European Commission decision expected early next year.

25 Nov 2013

UCSF investigator receives $89 M grant to research on anal cancer in people with HIV

A UC San Francisco investigator has won an eight-year grant from the National Cancer Institute for a major investigation into anal cancer, a debilitating and sometimes fatal disease largely concentrated among people with HIV.

25 Nov 2013

Research reveals that HPV infection is associated with higher subsequent risk of HIV infection

A study of 2,519 Kenyan men conducted by researchers at the University of North Carolina revealed that infection with the human papillomavirus (HPV) was associated with a higher subsequent risk of infection with HIV, a precursor to AIDS.

25 Nov 2013

New bill offers hope to HIV patients on transplant waiting lists

A bill scheduled to be signed into law today by President Obama reverses the longtime ban on letting HIV-infected people donate their organs for transplantation after death, a move that offers hope to thousands of HIV patients on transplant waiting lists.

22 Nov 2013

New documentary reveals how antiretroviral therapy transformed lives of HIV people in Africa

A new documentary produced by the University of East Anglia reveals how the lives of people with HIV in Africa have been transformed by antiretroviral therapy and highlights the crucial need for continued funding of the lifesaving treatment.

22 Nov 2013

High knowledge about HIV and risky sexual activity does not make teens more likely to get tested for HIV

Having high knowledge about HIV and engaging in risky sexual activity do not make high-school-aged teens more likely to get tested for HIV. Those are the findings of a new study by researchers at Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva University.

22 Nov 2013

Communicating with partners about parenting and HIV helps young people

A team from Royal Holloway University and St. Mary's Hospital, London, interviewed young people aged 18-23 who had transmitted HIV from their mothers - known as 'perinatally acquired HIV' (PAH). Previously most of these children would have died in childhood, but medication in the UK, means they are surviving into early adulthood.

22 Nov 2013

Younger people with HIV feel more isolated and stressed than older people

Case Western Reserve University researchers were surprised to learn that people younger than 50 years old with HIV feel more isolated and stressed than older people with the disease. They expected their study to reveal just the opposite.

21 Nov 2013

New method uses lab-on-a-chip device and cell phone to determine concentration of molecules

In developing nations, rural areas, and even one's own home, limited access to expensive equipment and trained medical professionals can impede the diagnosis and treatment of disease.

21 Nov 2013

DNA vaccine demonstrates potential to prevent and treat deadly MERS coronavirus

Inovio Pharmaceuticals, Inc. announced today that preclinical testing of a DNA synthetic vaccine for the virulent Middle East Respiratory Syndrome coronavirus (MERS) induced robust and durable immune responses, demonstrating the potential for a SynCon DNA vaccine to prevent and treat this deadly virus.

20 Nov 2013

State highlights: Calif. fines three insurers for denying therapy; Colo.'s Denver Health to shed jobs; Ambulance Co. agrees to pay feds $3M over fraud allegations

California officials said three of the state's largest health insurers illegally denied speech and occupational therapy to patients, and regulators fined one of the companies, Health Net Inc., $300,000 for repeated violations. The state Department of Managed Health Care said Monday that it ordered Health Net, Anthem Blue Cross and Blue Shield of California to stop denying medically necessary therapy in cases of developmental disabilities, autism and other medical conditions.

20 Nov 2013

Youth prefer rapid point-of-care HIV tests than traditional blood tests

Youth prefer, accept and receive HIV results more often when offered rapid finger prick or saliva swab tests rather than traditional blood tests according to a study by researchers at St. Michael's Hospital.

20 Nov 2013

Researchers use computer modeling to investigate complex relationships between spread and evolution of HIV virus

Researchers at Los Alamos National Laboratory are investigating the complex relationships between the spread of the HIV virus in a population (epidemiology) and the actual, rapid evolution of the virus (phylogenetics) within each patient's body.

20 Nov 2013

ORC to develop paper-based sensors to detect biomarkers in cancer patients

Pioneering research by the Optoelectronics Research Centre that could transform the care of cancer patients or people with infections in their own homes has received a significant grant from the Engineering and Physical Sciences Research Council.

19 Nov 2013

Gilead Sciences gets marketing authorization from European Commission for Vitekta tablets

Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for Vitekta (elvitegravir 85 mg and 150 mg) tablets, an integrase inhibitor for the treatment of HIV-1 infection in adults without known mutations associated with resistance to elvitegravir.

18 Nov 2013

Researchers take close look at medicine's highest volume activity

Laboratory testing is health care's single highest volume activity, with over 5 billion tests performed each year in the U.S.

18 Nov 2013

Protein shed by HIV-infected brain cells alters synaptic connections between networks of nerve cells

A protein shed by HIV-infected brain cells alters synaptic connections between networks of nerve cells, according to new research out of the University of Minnesota. The findings could explain why nearly half of all patients infected with the AIDS virus experience some level of neurocognitive impairment.

16 Nov 2013

HIV 1 News and Research

EMA grants accelerated assessment to Boehringer Ingelheim's Faldaprevir compound

Global health organizations join forces to raise awareness on dangers of fake medicines

CRISPR-Cas-system: A promising tool for genetic engineering

CHMP recommends approval of Otsuka's Deltyba for pulmonary multidrug-resistant tuberculosis

UCSF investigator receives $89 M grant to research on anal cancer in people with HIV

Research reveals that HPV infection is associated with higher subsequent risk of HIV infection

New bill offers hope to HIV patients on transplant waiting lists

New documentary reveals how antiretroviral therapy transformed lives of HIV people in Africa

High knowledge about HIV and risky sexual activity does not make teens more likely to get tested for HIV

Communicating with partners about parenting and HIV helps young people

Younger people with HIV feel more isolated and stressed than older people

New method uses lab-on-a-chip device and cell phone to determine concentration of molecules

DNA vaccine demonstrates potential to prevent and treat deadly MERS coronavirus

State highlights: Calif. fines three insurers for denying therapy; Colo.'s Denver Health to shed jobs; Ambulance Co. agrees to pay feds $3M over fraud allegations

Youth prefer rapid point-of-care HIV tests than traditional blood tests

Researchers use computer modeling to investigate complex relationships between spread and evolution of HIV virus

ORC to develop paper-based sensors to detect biomarkers in cancer patients

Gilead Sciences gets marketing authorization from European Commission for Vitekta tablets

Researchers take close look at medicine's highest volume activity

Protein shed by HIV-infected brain cells alters synaptic connections between networks of nerve cells

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest News